Narayan Prabhu 4
4 · REVIVA PHARMACEUTICALS HOLDINGS, INC. · Filed Oct 3, 2022
Insider Transaction Report
Form 4
Narayan Prabhu
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2022-09-30$1.66/sh+50,000$83,000→ 100,000 total